Paul T Wegener

USPTO Granted Patents = 6 (Patent Applications = 2)

CIPO Patents = 2

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 1.8

ph-index = 3

Forward Citations = 15(Granted Patents)

Location History:

New York, NY (US) (2010 - 2014)
San Diego, CA (US) (2016)

Company Filing History:

3 out of 3

Epitome Pharmaceuticals Limited

patents

2 out of 28

Mitsui Norin Co., Ltd.

patents

2 out of 832,912

Other

patents

where one patent can have more than one assignee

Years Active: 2010-2016

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9381001 - Tissue splitting biopsy needle (2016-07-05),

2. D749731 - Split biopsy needle (2016-02-16),

3. 8688416 - Methods and systems for improved pharmaceutical intervention in coagulation control (2014-04-01),

4. 8652533 - Durable biocides and disinfectants (2014-02-18),

5. 8124141 - Rapidly absorbing lipophilic skin compositions and uses therefor (2012-02-28),

6. 7770390 - Configurations and methods for wave energy extraction (2010-08-10),

Title: The Innovative Journey of Paul T Wegener

Introduction: Paul T Wegener is a renowned inventor based in San Diego, CA (US) known for his groundbreaking contributions to various fields.

Latest Patents: Paul T Wegener holds several patents in the areas of technology, healthcare, and consumer products, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Paul T Wegener has consistently pushed the boundaries of innovation, leading to the development of cutting-edge solutions that have revolutionized industries.

Collaborations: Throughout his career, Paul T Wegener has collaborated with leading companies, research institutions, and universities to bring his inventions to life, fostering a culture of creativity and excellence.

Conclusion: Paul T Wegener's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.